BlackRock’s CalciMedica CALC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-3,081
Closed -$29.4K – 5476
2025
Q1
$29.4K Sell
3,081
-109
-3% -$1.36K ﹤0.01% 5023
2024
Q4
$56.5K Sell
3,190
-23
-0.7% -$403 ﹤0.01% 4915
2024
Q3
$71.2K Buy
3,213
+565
+21% +$12.4K ﹤0.01% 4737
2024
Q2
$52.4K Buy
+2,648
New +$66.7K ﹤0.01% 4847
2023
Q1
– Sell
-9
Closed -$321 – 5588
2022
Q4
$321 Hold
9
– – ﹤0.01% 5685
2022
Q3
$1K Hold
9
– – ﹤0.01% 5719
2022
Q2
$1K Sell
9
-456
-98% -$31.1K ﹤0.01% 5771
2022
Q1
$40K Sell
465
-22
-5% -$2.1K ﹤0.01% 5456
2021
Q4
$63K Buy
487
+12
+3% +$2.33K ﹤0.01% 5369
2021
Q3
$110K Sell
475
-10
-2% -$2.81K ﹤0.01% 5118
2021
Q2
$184K Sell
485
-4,123
-89% -$1.35M ﹤0.01% 4910
2021
Q1
$1.79M Buy
4,608
+200
+5% +$299K ﹤0.01% 4318
2020
Q4
$8.96M Buy
4,408
+2,927
+198% +$4.32M ﹤0.01% 3418
2020
Q3
$1.32M Buy
+1,481
New +$1.54M ﹤0.01% 4025

Other funds holding CALC

BlackRock's CALC Position: Q2 2025 in Review

BlackRock sold out of CalciMedica (CALC) in Q2 2025, closing a stake of 3,081 shares — an estimated $29.4K sold.

BlackRock first reported a position in CALC in Q3 2020 and held it in 14 quarters. The position peaked at $8.96M in Q4 2020. 30 funds tracked by Wall St. Rank hold CALC as of Q2 2025.

  • BlackRock reported no remaining CalciMedica position as of Q2 2025 after selling out during the quarter.
  • BlackRock sold 3,081 CalciMedica shares in Q2 2025, an estimated $29.4K.
  • BlackRock first reported a position in CalciMedica in Q3 2020 and held it in 14 quarters.
  • BlackRock's CalciMedica position peaked at $8.96M in Q4 2020.
  • 30 funds tracked by Wall St. Rank held CalciMedica as of Q2 2025.

Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.